AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,700.00p
   
  • Change Today:
    -54.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 2,848,755
  • Market Cap: £165,918m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 882,891 £94,469,337
Aradhana Sarin 118,367 £12,665,269
Marcus Wallenberg 60,028 £6,422,996
Michel Demare 10,000 £1,070,000
Philip A J Broadley 8,025 £858,675
Tony Mok 3,500 £374,500
Sheri McCoy 1,736 £185,752
Diana Layfield 1,400 £149,800
Karen Knudsen 1,400 £149,800
Euan Ashley 1,150 £123,050
Nazneen Rahman 1,017 £108,819
Anna Manz 487 £52,109

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £10,794,714,367
Oddo Meriten Asset Management SA 100,885,181 £10,794,714,367
The Capital Group Companies, Inc. 77,540,115 £8,296,792,305
Wellington Management Company LLP 65,118,411 £6,967,669,977
Investor AB 51,587,810 £5,519,895,670

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,700.00p
Change Today -54.00p
% Change -0.50 %
52 Week High 13,276.00p
52 Week Low 9,667.00p
Volume 2,848,755
Shares Issued 1,550.64m
Market Cap £165,918m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.63% below the market average94.63% below the market average94.63% below the market average94.63% below the market average94.63% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
6.92% above the market average6.92% above the market average6.92% above the market average6.92% above the market average6.92% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Income
65.76% below the market average65.76% below the market average65.76% below the market average65.76% below the market average65.76% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
85.76% above the market average85.76% above the market average85.76% above the market average85.76% above the market average85.76% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 06-May-2025

Time Volume / Share Price
16:23 0 @ 10,718.00p
16:22 0 @ 10,714.00p
16:26 0 @ 10,718.00p
16:26 0 @ 10,718.00p
16:02 0 @ 10,738.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page